Anebulo Pharmaceuticals, Inc.
ANEB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $103 | $59 | $36 | $46 |
| - Cash | $10 | $12 | $13 | $15 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $92 | $48 | $22 | $31 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.05 | -0.052 | -0.061 | -0.09 |
| % Growth | 4.2% | 14.6% | 32% | – |
| Operating Cash Flow | -$1 | -$2 | -$2 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$1 |